Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ALDH2 Single Nucleotide Polymorphisms and Prognosis of Esophageal Cancer Patients

NCT07322627 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT07322627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07322627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ALDH2 Single Nucleotide Polymorphisms and Prognosis of Esophageal Cancer Patients
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 8, 2025
Completion date
October 31, 2027
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer